Life Sciences Bioanalytical Services
When it comes to the provision of Bioanalytical Services, few suppliers can match the expertise and achievements of SGS Life Science Services.
As one of Europe’s largest bioanalytical service providers, with three GLP compliant laboratories, we are able to serve pharmaceutical and biopharmaceutical companies of all sizes with a range of tests for drug development at both preclinical and clinical stages – from early to late phase. We also develop assays (including immunassays) from scratch.
SGS bioanalysis testing is underpinned by a large list of validated methods and biomarkers, and to maintain our reputation as an industry pioneer we have actively pursued the assay development and validation of some of the more innovative of these biomarkers with our clinical teams. To date we have over 700 assays validated. Our services span:
- Cell-based bioassays
- Immunogenecity testing
- Metabolite profiling
- ADME 14C
- Method transfer, development, optimization and validation
- PD bioanalysis (biomarkers)
- PK bioanalysis (small molecules & biopharmaceuticals)
Each service is overseen by highly skilled and trained skilled analysts, who are able to offer rapid high volume analyses that use a range of innovative techniques, including:
- Mass spectrometry (LC-MS/MS)
- UPLC technology
- Automated sample preparation using robotics or turbulent flow technology
- Large sample storage combined with bar code systems for sample storage of up to 400,000 samples
SGS is the world’s leading inspection, verification, testing and certification company. Our Life Science Services work with the top 20 pharmaceutical companies in the world, but every client receives the same high standard of service – no matter what their size.
Early Phase Clinical Trials Maxims
Discover the early phase clinical trial drug development fundamentals through our Maxims.